Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned Tumor Arrays
Source abstract
Abstract
Abstract Cancer immunotherapy based on the engineering of chimeric antigen receptors (CAR) on T cells has emerged as one of the most promising new therapies for patients with B‐cell malignancies. Preclinical assessments of essential CAR T cell functions such as trafficking and cytotoxicity are critical for accelerating the development of highly effective therapeutic candidates. However, current tools for evaluating CAR‐T functions lack sufficient precision. Here, a micropatterned tumor array (MiTA) is described that enables detailed and dynamic characterization of CAR T cell trafficking toward tumor‐cell islands and subsequent killing of tumor cells. It is shown that CAR T cells often merge into large clusters that envelop and kill the tumor cells with high efficiency. Significant differences are also measured between CAR T cells from different donors and between various CAR T cell constructs. Overall, the assay allows for multifaceted, dynamic, high‐content evaluation of CAR T trafficking, clustering, and killing and could eventually become a useful tool for immune‐oncology research and preclinical assessments of cell‐based immunotherapies.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: CAR-T cell therapy research · Nanowire Synthesis and Applications · Nanofabrication and Lithography Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
BioMEMS Resource Center Department of Surgery Massachusetts General Hospital Boston MA 02114 USA
Shiners Hospitals for Children Boston MA 02114 USA
Harvard Medical School Boston MA 02115 USA
Cellular Immunotherapy Program Massachusetts General Hospital Cancer Center Charlestown MA 02129 USA
Broad Institute of Harvard and MIT Cambridge MA 02142 USA
Funding
National Science Foundation · V Foundation for Cancer Research · Gabrielle’s Angel Foundation for Cancer Research
References (26)
Show source-provided references
1. 10.1126/scitranslmed.300593010.1126/scitranslmed.3005930 ↗
2. 10.1182/blood-2016-10-74877210.1182/blood-2016-10-748772 ↗
3. 10.1038/nrclinonc.2013.4610.1038/nrclinonc.2013.46 ↗
4. 10.1056/NEJMoa140722210.1056/NEJMoa1407222 ↗
5. 10.1056/NEJMoa170744710.1056/NEJMoa1707447 ↗
6. 10.1056/NEJMoa170991910.1056/NEJMoa1709919 ↗
7. 10.1056/NEJMoa170856610.1056/NEJMoa1708566 ↗
8. 10.1002/advs.20180184710.1002/advs.201801847 ↗
9. Brunner K. T. · Immunology · 1968 · 14 · 181
10. 10.1016/0022-1759(88)90310-910.1016/0022-1759(88)90310-9 ↗
11. 10.1016/S0022-1759(97)00098-710.1016/S0022-1759(97)00098-7 ↗
12. 10.1182/bloodadvances.201701282310.1182/bloodadvances.2017012823 ↗
13. 10.1371/journal.pone.019349810.1371/journal.pone.0193498 ↗
14. 10.1039/C8LC00256H10.1039/C8LC00256H ↗
15. 10.1038/s41598-017-13070-310.1038/s41598-017-13070-3 ↗
16. 10.1002/adhm.20190000110.1002/adhm.201900001 ↗
17. 10.1158/2159-8290.CD-17-083310.1158/2159-8290.CD-17-0833 ↗
18. 10.1172/jci.insight.8976210.1172/jci.insight.89762 ↗
19. 10.1038/s41568-018-0104-610.1038/s41568-018-0104-6 ↗
20. 10.1039/C5LC00514K10.1039/C5LC00514K ↗
21. 10.1096/fasebj.13.14.188310.1096/fasebj.13.14.1883 ↗
22. 10.1182/blood-2017-05-78135110.1182/blood-2017-05-781351 ↗
23. 10.1186/1746-1596-5-3010.1186/1746-1596-5-30 ↗
24. 10.1084/jem.2018237510.1084/jem.20182375 ↗
25. 10.1182/blood-2018-03-83541310.1182/blood-2018-03-835413 ↗
26. 10.1182/blood-2018-04-84270810.1182/blood-2018-04-842708 ↗